Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: Findings from the CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis) study

Authors
Category Primary study
ConferenceEuropean Journal of Neurology
Year 2012
This article has no abstract
Epistemonikos ID: 4d6fe9d531f8c4a82d3c718712fbede5e6f4bbdd
First added on: Apr 30, 2026